Literature DB >> 26812299

The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus.

Lucie Sosvorova1, Radmila Kanceva1, Josef Vcelak2, Lyudmila Kancheva1, Milan Mohapl3, Luboslav Starka1, Eva Havrdova4.   

Abstract

OBJECTIVES: Cytokine production and immune activation are associated with various pathological conditions including neurodegenerative disorders. One of them is multiple sclerosis (MS), known autoimmune disease. Inflammatory changes were also reported in normal pressure hydrocephalus (NPH), neurodegenerative disorder, which pathophysiology remains still unclear. The aim of this research was to compare the group of MS subjects with NPH patients and controls and to evaluate the potential inflammatory substance of NPH in comparison with autoimmune inflamed MS.
METHODS: The levels of IL-1β, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, INF-γ, sCD40L and TNF-α were measured in cerebrospinal fluid (CSF) and plasma in subjects with MS (n=15), NPH (n=18) and controls (n=11) by multiplex assay.
RESULTS: The increased levels of IL-1β, IL-6, IL-10, IL-21 and TNF-α in cerebrospinal fluid of NPH subjects in comparison with MS patients and controls were found. Regarding the MS patients, we have confirmed increased IL-33 levels in cerebrospinal fluid and periphery as well as the increase of IL-1β and IL-10 in cerebrospinal fluid and IL-4 and sCD40L in plasma.
CONCLUSION: The enlarged brain ventricles in NPH may repress and activate brain structures to the production of IL-1β, IL-6, IL-10, IL-21 and TNF-α, reflecting the inflammatory basis in NPH affected brain. The elevation of the above mentioned cytokines in MS was confirmed.

Entities:  

Year:  2015        PMID: 26812299

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  13 in total

1.  Role of tumor necrosis factor-alpha in zebrafish retinal neurogenesis and myelination.

Authors:  Xu-Dan Lei; Yan Sun; Shi-Jiao Cai; Yang-Wu Fang; Jian-Lin Cui; Yu-Hao Li
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

2.  Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.

Authors:  Patrice H Lalive; Mario Kreutzfeldt; Odile Devergne; Imke Metz; Wolfgang Bruck; Doron Merkler; Caroline Pot
Journal:  J Neuroinflammation       Date:  2017-07-24       Impact factor: 8.322

Review 3.  Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.

Authors:  M Guerra; J L Blázquez; E M Rodríguez
Journal:  Fluids Barriers CNS       Date:  2017-07-13

4.  CSF Cytokines in Aging, Multiple Sclerosis, and Dementia.

Authors:  William T Hu; Jennifer Christina Howell; Tugba Ozturk; Umesh Gangishetti; Alexander L Kollhoff; Jaime M Hatcher-Martin; Albert M Anderson; William R Tyor
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

Review 5.  An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS).

Authors:  Christopher Bolton
Journal:  Immun Ageing       Date:  2021-04-14       Impact factor: 6.400

6.  Proinflammatory cytokines and matrix metalloproteinases in CSF of patients with VZV vasculopathy.

Authors:  Dallas Jones; Enrique Alvarez; Sean Selva; Don Gilden; Maria A Nagel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-13

7.  Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration.

Authors:  Claudia La Rocca; Fortunata Carbone; Veronica De Rosa; Alessandra Colamatteo; Mario Galgani; Francesco Perna; Roberta Lanzillo; Vincenzo Brescia Morra; Giuseppe Orefice; Ilaria Cerillo; Ciro Florio; Giorgia Teresa Maniscalco; Marco Salvetti; Diego Centonze; Antonio Uccelli; Salvatore Longobardi; Andrea Visconti; Giuseppe Matarese
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

8.  Evaluating sex hormones and cytokine profile in Egyptian females with relapsing-remitting multiple sclerosis.

Authors:  Forayssa M Talaat; Noha T Abokrysha; Dalia M Labib; Engy El Khateeb; Ghada Hatem Abd El Aziz
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-11-03

9.  Inflammatory Markers in Cerebrospinal Fluid from Patients with Hydrocephalus: A Systematic Literature Review.

Authors:  Sara Diana Lolansen; Nina Rostgaard; Eva Kjer Oernbo; Marianne Juhler; Anja Hviid Simonsen; Nanna MacAulay
Journal:  Dis Markers       Date:  2021-02-02       Impact factor: 3.434

10.  Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis.

Authors:  Qi Wu; Qin Wang; Jennifer Yang; Jacob Ws Martens; Elizabeth A Mills; Aiya Saad; Pavani Chilukuri; Catherine A Dowling; Yang Mao-Draayer
Journal:  J Cent Nerv Syst Dis       Date:  2021-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.